NCT06819735
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06819735
Title Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors (DOMISOL)
Acronym DOMISOL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Domain Therapeutics Australia Pty Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Macquarie University Clinical Trial Unit RECRUITING North Ryde New South Wales 2109 Australia Details
Cancer Research SA RECRUITING Adelaide South Australia 5000 Australia Details
Peninsula & South Eastern Haematology & Oncology Group RECRUITING Frankston Victoria 3199 Australia Details
Cabrini Health Limited RECRUITING Malvern Victoria 3144 Australia Details
One Clinical Research Pty Ltd RECRUITING Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field